{
    "clinical_study": {
        "@rank": "70417", 
        "brief_summary": {
            "textblock": "The investigators hope to learn whether perfusion CT is a useful way to assess primary\n      cervical tumor microenvironment and whether there is a relationship between pretreatment\n      perfusion CT measurements and primary cervical tumor size, lymph node involvement (as\n      assessed by standard of care pretreatment fludeoxyglucose Positron emission tomography/CT\n      (FDG-PET/CT)), and treatment response (as assessed by standard of care 3-month post-therapy\n      FDG-PET/CT)."
        }, 
        "brief_title": "Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer", 
        "completion_date": {
            "#text": "June 2016", 
            "@type": "Anticipated"
        }, 
        "condition": "Cervical Cancer", 
        "condition_browse": {
            "mesh_term": "Uterine Cervical Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion criteria:\n\n          -  >18 years old\n\n          -  with biopsy-proven squamous, adenocarcinoma or adenosquamous cervical cancer\n\n          -  no history of prior pelvic radiation and should be able to receive chemoradiation\n\n          -  non-pregnant women who have not previously undergone a hysterectomy, as that would\n             have removed the cervix.\n\n          -  able to give informed consent\n\n        Exclusion criteria:\n\n          -  Subjects whose tumors are not FDG avid on the pre-therapy PET.\n\n          -  Allergy or inability to receive iodinated CT contrast"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Approximately 12-15 cervical cancer patients are referred for radiation each year."
            }
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01805141", 
            "org_study_id": "GYNCVX0003", 
            "secondary_id": "25821"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Cervix Uteri", 
        "lastchanged_date": "May 19, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Stanford", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "94305"
                }, 
                "name": "Stanford University School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_groups": "1", 
        "official_title": "Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer", 
        "overall_official": {
            "affiliation": "Stanford University", 
            "last_name": "Elizabeth Kidd, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Suspended", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Treatment response will be assessed using a post-treatment FDG-PET/CT to evaluate for complete response, persistent disease or new disease.  The association between pre-treatment perfusion CT parameters and response on the post-treatment FDG-PET/CT will be analyzed.", 
            "measure": "Measure perfusion in primary cervical tumors using perfusion CT.", 
            "safety_issue": "No", 
            "time_frame": "3-6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01805141"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Stanford University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Stanford University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Cross-Sectional", 
        "study_type": "Observational", 
        "verification_date": "May 2014", 
        "why_stopped": "Equipment issue"
    }
}